scholarly article | Q13442814 |
P50 | author | Eva Cecilie Bonefeld-Jørgensen | Q68132652 |
P2093 | author name string | Mandana Ghisari | |
Manhai Long | |||
P2860 | cites work | Does perinatal exposure to endocrine disruptors induce autism spectrum and attention deficit hyperactivity disorders? Review | Q22242325 |
Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice | Q23911989 | ||
Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha | Q23914416 | ||
Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age | Q24629288 | ||
Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth | Q24647791 | ||
Do perfluoroalkyl compounds impair human semen quality? | Q24657367 | ||
Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort | Q24680484 | ||
Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth | Q24680500 | ||
Problems for risk assessment of endocrine-active estrogenic compounds | Q24812789 | ||
Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals | Q28204565 | ||
CYP1A1 induction in the colon by serum: involvement of the PPARα pathway and evidence for a new specific human PPREα site | Q28477045 | ||
Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism | Q28576821 | ||
Alterations in gene expression and testosterone synthesis in the testes of male rats exposed to perfluorododecanoic acid | Q28577431 | ||
The aryl hydrocarbon receptor complex | Q29618805 | ||
Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction. | Q30320256 | ||
Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms | Q33534029 | ||
Induction of cytochrome P4501A1. | Q33636653 | ||
Thyroidal dysfunction and environmental chemicals--potential impact on brain development | Q33905546 | ||
Perfluorinated compounds--exposure assessment for the general population in Western countries | Q34012353 | ||
The developmental toxicity of perfluoroalkyl acids and their derivatives | Q34331477 | ||
Molecular basis of thyroid hormone-dependent brain development | Q34436471 | ||
Partition of environmental chemicals between maternal and fetal blood and tissues | Q34540744 | ||
Responses of the liver to perfluorinated fatty acids with different carbon chain length in male and female mice:in relation to induction of hepatomegaly, peroxisomal beta-oxidation and microsomal 1-acylglycerophosphocholine acyltransferase | Q34562548 | ||
Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers | Q34680365 | ||
Effects of perfluoroalkyl compounds on mRNA expression levels of thyroid hormone-responsive genes in primary cultures of avian neuronal cells | Q34701773 | ||
Dioxin-like activities in serum across European and Inuit populations | Q34767885 | ||
Estimating consumer exposure to PFOS and PFOA. | Q34770851 | ||
Maternal levels of perfluorinated chemicals and subfecundity | Q34931926 | ||
The evolutionary and integrative roles of transthyretin in thyroid hormone homeostasis | Q34962782 | ||
Homology modelling of the nuclear receptors: human oestrogen receptorbeta (hERbeta), the human pregnane-X-receptor (PXR), the Ah receptor (AhR) and the constitutive androstane receptor (CAR) ligand binding domains from the human oestrogen receptor a | Q35113333 | ||
Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study | Q35461376 | ||
Serum vaccine antibody concentrations in children exposed to perfluorinated compounds | Q35478107 | ||
Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age. | Q35591930 | ||
Thyroid function and perfluoroalkyl acids in children living near a chemical plant | Q36115374 | ||
Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice | Q36245081 | ||
Environmental chemicals as thyroid hormone analogues: new studies indicate that thyroid hormone receptors are targets of industrial chemicals? | Q36252607 | ||
Chemically activated luciferase gene expression (CALUX) cell bioassay analysis for the estimation of dioxin-like activity: critical parameters of the CALUX procedure that impact assay results | Q36295204 | ||
Contamination, bioaccumulation and toxic effects of perfluorinated chemicals (PFCs) in the water environment: a review paper | Q37598518 | ||
Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art. | Q37852047 | ||
Immunotoxicity of perfluorinated compounds: recent developments. | Q37959888 | ||
Dioxin-like activity in environmental and human samples from Greenland and Denmark | Q38031723 | ||
Perfluorinated compounds | Q38040335 | ||
Species-specific antagonism of Ah receptor action by 2,2',5,5'-tetrachloro- and 2,2',3,3'4,4'-hexachlorobiphenyl | Q38288142 | ||
Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with age of puberty among children living near a chemical plant | Q39189165 | ||
Effects of selected phytoestrogens and their mixtures on the function of the thyroid hormone and the aryl hydrocarbon receptor | Q39281290 | ||
Plastic components affect the activation of the aryl hydrocarbon and the androgen receptor | Q40009773 | ||
Impact of environmental chemicals on the thyroid hormone function in pituitary rat GH3 cells | Q40362684 | ||
T-screen to quantify functional potentiating, antagonistic and thyroid hormone-like activities of poly halogenated aromatic hydrocarbons (PHAHs). | Q40363049 | ||
PPARalpha activation potentiates AhR-induced CYP1A1 expression | Q40378800 | ||
Down regulation of hepatic PPARalpha function by AhR ligand. | Q40483146 | ||
Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. | Q40497007 | ||
PPARalpha-dependent modulation of hepatic CYP1A by clofibric acid in rats | Q40558933 | ||
Activation of estrogen response element dependent transcription by thyroid hormone with increase in estrogen receptor levels in a rat pituitary cell line, GH3. | Q40568752 | ||
Effects of currently used pesticides in the AhR-CALUX assay: comparison between the human TV101L and the rat H4IIE cell line | Q40613580 | ||
Alterations in cell membrane properties caused by perfluorinated compounds | Q40643223 | ||
Ah receptor signaling pathways | Q40955603 | ||
Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals | Q41207775 | ||
An in vitro test system for thyroid hormone action | Q41232123 | ||
Depletion of L-3,5,3'-Triiodothyronine and L-Thyroxine in Euthyroid Calf Serum for Use in Cell Culture Studies of the Action of Thyroid Hormone* | Q41621030 | ||
Molecular determinants of hormone mimicry: halogenated aromatic hydrocarbon environmental agents | Q41714658 | ||
AhR and PPARalpha: antagonistic effects on CYP2B and CYP3A, and additive inhibitory effects on CYP2C11. | Q42475981 | ||
Characterization of hepatic responses of rat to administration of perfluorooctanoic and perfluorodecanoic acids at low levels | Q42679333 | ||
Perfluorooctane sulfonate (PFOS) affects hormone receptor activity, steroidogenesis, and expression of endocrine-related genes in vitro and in vivo | Q42715289 | ||
Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARα) by perfluoroalkyl acids (PFAAs): further investigation of C4-C12 compounds | Q42723687 | ||
Determining the molecular interactions of perfluorinated carboxylic acids with human sera and isolated human serum albumin using nuclear magnetic resonance spectroscopy. | Q42915431 | ||
Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system | Q43238768 | ||
Determinants of plasma concentrations of perfluorooctanesulfonate and brominated organic compounds in Nunavik Inuit adults (Canada). | Q43293379 | ||
Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver | Q43717832 | ||
Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland | Q43822053 | ||
Dietary accumulation of perfluorinated acids in juvenile rainbow trout (Oncorhynchus mykiss). | Q44263463 | ||
Effects of co-exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin and perfluorooctane sulfonate or perfluorooctanoic acid on expression of cytochrome P450 isoforms in chicken (Gallus gallus) embryo hepatocyte cultures | Q44435332 | ||
Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation | Q44458021 | ||
Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations | Q44458023 | ||
Effects of a mixture of polychlorinated biphenyls (Aroclor 1254) on the transcriptional activity of thyroid hormone receptor | Q44753266 | ||
The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. | Q44809487 | ||
Characterisation of human exposure pathways to perfluorinated compounds--comparing exposure estimates with biomarkers of exposure | Q45357022 | ||
Molecular characterization of cytochrome P450 1A and 3A and the effects of perfluorooctanoic acid on their mRNA levels in rare minnow (Gobiocypris rarus) gills | Q45674172 | ||
Impact of neonatal thyroid hormone insufficiency and medical morbidity on infant neurodevelopment and attention following preterm birth | Q46056834 | ||
Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin | Q46085092 | ||
Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain | Q46124668 | ||
Perfluorinated compounds in human breast milk from several Asian countries, and in infant formula and dairy milk from the United States | Q46206901 | ||
Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths | Q46421733 | ||
Attention-deficit and hyperactive neurobehavioural characteristics induced by perinatal hypothyroidism in rats. | Q46427382 | ||
Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort | Q46442964 | ||
The Ah receptor: a regulator of the biochemical and toxicological actions of structurally diverse chemicals | Q46481525 | ||
Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate | Q46687851 | ||
Lipid homeostasis and oxidative stress in the liver of male rats exposed to perfluorododecanoic acid | Q46889241 | ||
Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography/single quadrupole mass spectrometry. | Q48444775 | ||
Effects of environmental synthetic chemicals on thyroid function. | Q52532228 | ||
Perfluoroalkyl acids and related chemistries--toxicokinetics and modes of action. | Q53225736 | ||
Species-Specific Recombinant Cell Lines as Bioassay Systems for the Detection of 2,3,7,8-Tetrachlorodibenzo-p-dioxin-like Chemicals | Q56627613 | ||
Serum concentrations of major perfluorinated compounds among the general population in Korea: dietary sources and potential impact on thyroid hormones | Q57224872 | ||
Trans-Placental Transfer of Thirteen Perfluorinated Compounds and Relations with Fetal Thyroid Hormones | Q58765976 | ||
Tissue bioaccumulation patterns, xenobiotic biotransformation and steroid hormone levels in Atlantic salmon (Salmo salar) fed a diet containing perfluoroactane sulfonic or perfluorooctane carboxylic acids | Q63284920 | ||
Acute toxicity of perfluorodecanoic acid in C57BL/6 mice differs from 2,3,7,8-tetrachlorodibenzo-p-dioxin | Q69440217 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 8045-8056 | |
P577 | publication date | 2013-03-29 | |
P1433 | published in | Environmental Science and Pollution Research | Q15750698 |
P1476 | title | Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor | |
P478 | volume | 20 |
Q48051836 | Adsorption of perfluorocarboxylic acids at the silica surface |
Q38709661 | Aryl hydrocarbon receptor (AHR) is a potential tumour suppressor in pituitary adenomas |
Q36456151 | Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010 |
Q99556536 | Associations between prenatal maternal exposure to per- and polyfluoroalkyl substances (PFAS) and polybrominated diphenyl ethers (PBDEs) and birth outcomes among pregnant women in San Francisco |
Q64260723 | Associations of Fetal Growth Outcomes with Measures of the Combined Xenoestrogenic Activity of Maternal Serum Perfluorinated Alkyl Acids in Danish Pregnant Women |
Q35250864 | Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort |
Q60913748 | Autism spectrum disorders, endocrine disrupting compounds, and heavy metals in amniotic fluid: a case-control study |
Q47133909 | Behavioral difficulties in 7-year old children in relation to developmental exposure to perfluorinated alkyl substances |
Q34730721 | Biomonitoring and hormone-disrupting effect biomarkers of persistent organic pollutants in vitro and ex vivo |
Q34430357 | Breast cancer risk after exposure to perfluorinated compounds in Danish women: a case-control study nested in the Danish National Birth Cohort |
Q62387081 | Childhood perfluoroalkyl substance exposure and executive function in children at 8 years |
Q93123912 | Derivation of a chronic reference dose for perfluorohexane sulfonate (PFHxS) for reproductive toxicity in mice |
Q60284100 | Developmental Origins of Disease: Emerging Prenatal Risk Factors and Future Disease Risk |
Q38762454 | Endocrine Disruption and In Vitro Ecotoxicology: Recent Advances and Approaches |
Q43307803 | Endocrine-disrupting effects of compounds in Danish streams |
Q89722945 | Evaluating thyroid hormone disruption: investigations of long-term neurodevelopmental effects in rats after perinatal exposure to perfluorohexane sulfonate (PFHxS) |
Q89349832 | Exposure to perfluoroalkyl substances and associations with serum thyroid hormones in a remote population of Alaska Natives |
Q37504193 | Health effects associated with measured levels of contaminants in the Arctic |
Q36095017 | Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013. |
Q64138178 | Maternal Plasma per- and Polyfluoroalkyl Substance Concentrations in Early Pregnancy and Maternal and Neonatal Thyroid Function in a Prospective Birth Cohort: Project Viva (USA) |
Q93062778 | No evidence of the role of early chemical exposure in the development of β-cell autoimmunity |
Q44987459 | Nordic research on per- and polyfluoroalkyl substances (PFASs). |
Q96955204 | Per- and poly-fluoroalkyl substances and bone mineral density: Results from the Bayesian weighted quantile sum regression |
Q39402678 | Perfluorinated compounds affect the function of sex hormone receptors |
Q36968190 | Perfluoroalkyl Acids in Maternal Serum and Indices of Fetal Growth: The Aarhus Birth Cohort |
Q30314285 | Perfluoroalkyl acids in aqueous samples from Germany and Kenya |
Q38265262 | Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: a systematic review |
Q50041743 | Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study |
Q33899365 | Perfluorooctane sulfonate affects intestinal immunity against bacterial infection |
Q38728291 | Perfluorooctanoic acid induces mitochondrial dysfunction in MC3T3-E1 osteoblast cells |
Q38186063 | Polyfluorinated alkyl phosphate ester surfactants - current knowledge and knowledge gaps |
Q34524819 | Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women |
Q37674876 | Prenatal Exposure to Perfluoroalkyl Substances and Adiposity in Early and Mid-Childhood |
Q89089334 | Prenatal Exposure to Perfluoroalkyl Substances and IQ Scores at Age 5; a Study in the Danish National Birth Cohort |
Q62387101 | Prenatal and childhood exposure to perfluoroalkyl substances (PFAS) and measures of attention, impulse control, and visual spatial abilities |
Q64128838 | Prenatal and childhood exposure to poly- and perfluoroalkyl substances (PFAS) and cognitive development in children at age 8 years |
Q44964762 | Prenatal exposure to perfluoroalkyl substances and the risk of congenital cerebral palsy in children |
Q62086877 | Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food |
Q42705686 | Structure-activity relations in binding of perfluoroalkyl compounds to human thyroid hormone T3 receptor |
Q39387486 | The Complex Biology of the Aryl Hydrocarbon Receptor and Its Role in the Pituitary Gland. |